Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry J Fry

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Blood|November 4, 2017
Anti-CD19 resistance can "stem" from progenitorsNirali N Shah, Terry J Fry
Current Opinion in Hematology|September 22, 2015
Challenges and opportunities of allogeneic donor-derived CAR T cellsYinmeng Yang, Elad Jacoby, Terry J Fry
Current Hematologic Malignancy Reports|July 24, 2019
Multi-Specific CAR Targeting to Prevent Antigen EscapeZachary Walsh, Savannah Ross, Terry J Fry
Pediatric Clinics of North America|March 24, 2010
The graft-versus-tumor effect in pediatric malignancyTerry J Fry, Andre Willasch, Peter Bader
Frontiers in Pediatrics|October 21, 2015
Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute LeukemiaHaneen Shalabi, Anne Angiolillo, Terry J Fry
Clinical Immunology (Orlando, Fla.)|June 13, 2006
Autoimmunity during lymphopenia: a two-hit modelTom Krupica, Terry J Fry, Crystal L Mackall
Frontiers in Oncology|May 22, 2014
Murine models of acute leukemia: important tools in current pediatric leukemia researchElad Jacoby, Christopher D Chien, Terry J Fry
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Cytokine signals in T-cell homeostasisMartin Guimond, Terry J Fry, Crystal L Mackall
Plos One|September 28, 2017
Myeloablative hematopoietic stem cell transplantation improves survival but is not curative in a pre-clinical model of myelodysplastic syndromeYang Jo Chung, Terry J Fry, Peter D Aplan
Leukemia & Lymphoma|August 23, 2006
IL-7 in allogeneic transplant: clinical promise and potential pitfallsKristen M Snyder, Crystal L Mackall, Terry J Fry
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Blood|November 4, 2017
Anti-CD19 resistance can "stem" from progenitorsNirali N Shah, Terry J Fry
Current Opinion in Hematology|September 22, 2015
Challenges and opportunities of allogeneic donor-derived CAR T cellsYinmeng Yang, Elad Jacoby, Terry J Fry
Current Hematologic Malignancy Reports|July 24, 2019
Multi-Specific CAR Targeting to Prevent Antigen EscapeZachary Walsh, Savannah Ross, Terry J Fry
Pediatric Clinics of North America|March 24, 2010
The graft-versus-tumor effect in pediatric malignancyTerry J Fry, Andre Willasch, Peter Bader
Frontiers in Pediatrics|October 21, 2015
Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute LeukemiaHaneen Shalabi, Anne Angiolillo, Terry J Fry
Clinical Immunology (Orlando, Fla.)|June 13, 2006
Autoimmunity during lymphopenia: a two-hit modelTom Krupica, Terry J Fry, Crystal L Mackall
Frontiers in Oncology|May 22, 2014
Murine models of acute leukemia: important tools in current pediatric leukemia researchElad Jacoby, Christopher D Chien, Terry J Fry
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Cytokine signals in T-cell homeostasisMartin Guimond, Terry J Fry, Crystal L Mackall
Plos One|September 28, 2017
Myeloablative hematopoietic stem cell transplantation improves survival but is not curative in a pre-clinical model of myelodysplastic syndromeYang Jo Chung, Terry J Fry, Peter D Aplan
Leukemia & Lymphoma|August 23, 2006
IL-7 in allogeneic transplant: clinical promise and potential pitfallsKristen M Snyder, Crystal L Mackall, Terry J Fry
Pageof 13